Provaris Energy Ltd (ASX:PV1, OTC:GBBLF, FRA:WS90) has completed a $1 million placement to support key 2026 technical ...

Hawaii Tribune-Herald ...

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip ...

“As we reported last month, we have achieved over 50% of the current targeted enrollment in the first trial in this Phase 3 program (COVE-2) in the U.S. and have also been enrolling U.S. patients in ...

The online programs are designed for working professionals who need flexible pathways to access higher education.

Matching qualified and interested job seekers with available jobs is at the heart of the work that we do at the Santa Barbara ...

At the center of AIM's strategy is Ampligen ® (rintatolimod), the Company's proprietary TLR3 agonist immunotherapy, which is being evaluated in the ongoing Phase 2 DURIPANC study in combination with ...

The state sued Step Up on Second and other organizations in January 2024 alleging fraud related to the Homekey program.

President Prabowo Subianto has instructed the government to continue and strengthen agricultural development programs in Papua, citing their direct benefits to local communities and farmers, ...

June 30, 2026Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of ...

Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress. Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Bio ...